article · BMJ Open
OBJECTIVES: This study assessed women's preferences and concerns on human papillomavirus (HPV) self-sample and healthcare provider (HCP) sample collections for cervical cancer screening in Ibadan, Nigeria. DESIGN: This was a cross-sectional study. SETTINGS: Study was conducted in primary healthcare centres in selected peri-urban and urban communities in Ibadan, Nigeria. PARTICIPANTS: A total of 620 sexually active women aged 25-65 years were recruited for the study. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was the preferred method of collecting cervico-vaginal sample (self-sampling or provider sampling) by women. Secondary outcomes were observed differences in preferences between women in urban and peri-urban communities, reasons for these preferences, concerns on each method of sample collection and preferred locations for self-sample collection. RESULTS: Overall, more women preferred HCP sample collection (51.6%) than self-sampling collection (48.4%) (p=0.422). Self-sampling was more preferred among urban participants (53.7%), while HCP sample collection was more preferred among peri-urban participants (56.6%) (p=0.011). Peri-urban women preferred HCP sample collection due to clinician's expertise (90.2%) and result reliability (57.8%), while urban women preferred self-sample collection because of privacy (74.2%), comfort (62.1%) and confidentiality (55%). Most women (63.7%) preferred to self-sample in a private place in the hospital while others preferred to self-sample at home (36.3%). CONCLUSION: Preferences for HPV sample collection methods were similar, with a slightly higher proportion of women favouring HCP collection compared with self-sampling. Self-sampling was an acceptable complementary option to HCP-based sampling. Factors such as age, media access, and awareness of HPV were associated with women's preferences for sample collection methods. Integrating flexible, facility-based self-sampling within existing health services may help address contextual barriers and could potentially improve participation in cervical cancer screening programmes in Nigeria.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1136/bmjopen-2025-110692
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.